M Peyrot, RR Rubin, T Lauritzen, SE Skovlund … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Patient and provider attitudes differ significantly across countries,
controlling for individual characteristics. Patients rate the clinical efficacy
of insulin as low and would blame themselves if they had to start insulin ... Cited by 114 - Related articles - BL Direct - All 11 versions
M Peyrot, RR Rubin, T Lauritzen, SE … - Diabetes Care, 2005 - emedicina.lt Sergant 2 tipo cukriniu diabetu, sutrinka tiek insulino sekrecija, tiek jo
veikimas. Insulino sekrecijos sutriki mas progresuoja – tai įrodo
prospektyvus diabeto tyri mas [1] (UKPDS), atliktas Jungtinėje ... Related articles - View as HTML
WH Polonsky, L Fisher, S Guzman, L Villa- … - Diabetes Care, 2005 - Am Diabetes Assoc To achieve tight glycemic control in type 2 diabetic patients, it may be
advantageous to introduce insulin therapy much earlier in the disease course
(1). Unfortunately, many patients are reluctant to begin insulin and may ... Cited by 100 - Related articles - BL Direct - All 6 versions
JB Brown, GA Nichols, A Perry - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A prospective, population-based study using
retrospective observational data. We identified all 7,208 complete courses of
treatment with nondrug therapy, sulfonylurea monotherapy, metformin ... Cited by 162 - Related articles - BL Direct - All 7 versions
KH Summers, SL Szeinbach, SM Lenox - Clinical therapeutics, 2004 - Elsevier US residents with type 1 or 2 diabetes mellitus who responded to a year-2001
mail survey completed a 19-item self-administered questionnaire designed to
assess respondents' expectations of attributes related to the VS and IIPD. ... Cited by 57 - Related articles - All 6 versions
J Meece - The Diabetes Educator, 2006 - tde.sagepub.com The burden that diabetes has placed on the health care system as a result of
increased morbidity, mortality, and economic costs has continued to increase
with each new decade. A review of data from the Third National Health and ... Cited by 56 - Related articles - All 3 versions
- ►diabetesjournals.org N Freemantle, L Blonde, D Duhot, M Hompesch … - Diabetes Care, 2005 - Am Diabetes Assoc Inhaled insulin (INH, Exubera) is under investigation for preprandial treatment
of patients with type 1 and type 2 diabetes (1–3). This dry-powder insulin
formulation is delivered by aerosol, permitting the noninvasive ... Cited by 102 - Related articles - All 7 versions
WH Polonsky, RA Jackson - Clinical Diabetes, 2004 - Am Diabetes Assoc Patients with type 2 diabetes are often reluctant to begin insulin and, in many
cases, delay the start of insulin therapy for quite lengthy periods of time.
Patients may refuse insulin outright (“Look, doc, there is just no way I ... Cited by 48 - Related articles - BL Direct - All 2 versions
BR Shah, JE Hux, A Laupacis, B Zinman, C … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Using administrative data, we studied all
non-insulin-requiring diabetic patients in eastern Ontario aged 65 or older who
had A1c results >8% between September 1999 and August 2000. Drug ... Cited by 124 - Related articles - All 6 versions
M Korytkowski - International journal of obesity and related metabolic …, 2002 - ncbi.nlm.nih.gov Insulin therapy has proven benefits in Type 2 diabetes patients when combination
therapy has failed. However, there is some reluctance by both patients and
healthcare professionals to initiate insulin therapy. This reluctance has ... Cited by 203 - Related articles - BL Direct - All 4 versions
